Skip to main content
Caplight Logo









Minghui Pharmaceutical

Minghui Pharmaceutical

Private
ShanghaiHealthcare & Life Scienceshttps://minghuipharma.com

Last Round

pre_ipo

Aug 7, 2025

Est. Valuation

$545M

Total Funding Raised

$11.13M

Company Overview

Minghui Pharmaceutical is a biopharmaceutical company that develops transformative medicines for patients with oncology and autoimmune conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall molecule therapeuticsdrug discoveryoncologyautoimmune diseasesbiotechclinical-stagelicensing agreementantibody-drug conjugatesADCbispecific antibodiesdrug pipelinepreclinical developmentpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Minghui Pharmaceutical Comparables

Compare Minghui Pharmaceutical with similar companies based on industry and business-model similarity.

Minghui Pharmaceutical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TechnoDerma Medicines Inc.
75%
InnoCare Pharma Limited
72%
MediLink Therapeutics
69%

Minghui Pharmaceutical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
pre_ipoAug 7, 2025
SeedApr 1, 2018

Minghui Pharmaceutical Investors

Notable investors and investment history

Minghui Pharmaceutical investors
InvestorRounds
BioTrack Capitalpre_ipo
Boyuan CapitalVC Round
TF CapitalVC Round, pre_ipo
OrbiMedpre_ipo
5Y Capitalpre_ipo
New Day Venture Capitalpre_ipo
Qiming Venture Partnerspre_ipo

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 7, 2025

    $131M round led by OrbiMed and Qiming Venture Partners.

Minghui Pharmaceutical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Minghui Pharmaceutical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Minghui Pharmaceutical's valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range-
Year Founded2018
Last FundingAug 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?